PBLA   $1.04  -10.57% Market Closed

Panbela Therapeutics Inc
Total Cash 907.00K
totalCashPerShare 3.538
EBITDA
Total Debt 5.19M
quickRatio 0.119
currentRatio 0.212
Total Revenue
debtToEquity
Revenue/Share
ROA -1.91868
ROE
grossProfits
freeCashflow -12.34M
operatingCashflow -27.17M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 4.45M
forwardPE -0.021945627
floatShares 256.32K
sharesOutstanding 3.48M
sharesShort 106.97K
sharesShortPriorMonth 46.36K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.01%
Short Ratio help_outline 0.07%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -16.574
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -23.52M
trailingEps -157.02%
forwardEps -30.53%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -2.01 1Q 2024
institutionsCount 10
lastUpdated April 1, 2024, 2:53 p.m.